Hebrew U's Yissum Licenses Stem-Cell IP to TheraCell for Spinal Fusion Procedures | GenomeWeb

Yissum Research Development Company, the tech-transfer arm of the Hebrew University of Jerusalem, has licensed a portfolio of stem cell-related technologies to biotech firm TheraCell for use in regenerative medical procedures such as spinal fusion.

The technology was invented by a team led by Dan Gazit, a professor from the faculty of dental medicine at Hebrew University. It includes a biologically compatible, oxygenated gel that improves bone regeneration and fusion of bone grafts by increasing local oxygenation and fusion rates at the surgical site.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.